Allogeneic vaccine
Showing 1 - 25 of >10,000
Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell
Not yet recruiting
- Cytomegaloviral Infection
- Hematopoietic and Lymphoid System Neoplasm
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 16, 2022
Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell
Recruiting
- Hematologic Diseases
- COVID-19 vaccine(donor)
- COVID-19 vaccine(patient)
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Nov 8, 2022
Bone Marrow Transplant, Stem Cell Transplant Trial in Aurora (Zoster Vaccine Recombinant)
Not yet recruiting
- Bone Marrow Transplant
- Stem Cell Transplant
- Zoster Vaccine Recombinant
-
Aurora, ColoradoUniversity of Colorado Hospital
Mar 17, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Tumor Trial in Houston (Recombinant
Active, not recruiting
- Allogeneic Hematopoietic Stem Cell Transplant Recipient
- Hematopoietic and Lymphoid Cell Neoplasm
- Recombinant Human Papillomavirus Nonavalent Vaccine
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- Laboratory Biomarker Analysis
- Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Jan 4, 2023
Multiple Myeloma Trial in Baltimore (biological, drug, other)
Recruiting
- Multiple Myeloma
- GM-CSF vaccine
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 6, 2022
Cytomegalovirus Infection Trial in Boston (mRNA-1647, Placebo)
Not yet recruiting
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 4, 2023
Cytomegaloviral Infection, Hematopoietic Cell Transplant Recipient Trial in Duarte (Laboratory Biomarker Analysis, Multi-peptide
Recruiting
- Cytomegaloviral Infection
- Hematopoietic Cell Transplant Recipient
- Laboratory Biomarker Analysis
- Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 14, 2022
Acute Myelogenous Leukemia Trial in Boston (decitabine, DC/AML fusion cells)
Recruiting
- Acute Myelogenous Leukemia
- decitabine
- DC/AML fusion cells
-
Boston, Massachusetts
- +1 more
Nov 15, 2021
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)
Terminated
- Myelodysplastic Syndrome
- +2 more
- GVAX
- +6 more
-
Boston, Massachusetts
- +3 more
Jun 30, 2022
Advanced NSCLC Trial in Birmingham, Southampton (AST-VAC2)
Active, not recruiting
- Advanced Non-small Cell Lung Cancer
- AST-VAC2
-
Birmingham, United Kingdom
- +1 more
Mar 29, 2022
Ovarian Cancer Trial in Groningen (DCP-001)
Recruiting
- Ovarian Cancer
- DCP-001
-
Groningen, NetherlandsUMCG
Nov 25, 2021
Glioblastoma Trial in Minneapolis (Treatment with hP1A8)
Active, not recruiting
- Glioblastoma
- Treatment with hP1A8
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 30, 2021
Tick Borne Encephalitis Trial in Vienna (TBE virus vaccine)
Completed
- Tick Borne Encephalitis
- TBE virus vaccine
-
Vienna, AustriaMedical University of Vienna, Department of Medicine I, Division
Jan 27, 2022
Neuroblastoma Trial in Houston (Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN
Active, not recruiting
- Neuroblastoma
- Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN neuroblastoma cells
- Cytoxan
-
Houston, TexasTexas Children's Hospital
Mar 25, 2022
Myelodysplastic Syndrome RAEB-I or RAEB-II, Refractory Acute Myeloid Leukemia, Refractory CML Myeloid Blast Crisis Trial in
Completed
- Myelodysplastic Syndrome RAEB-I or RAEB-II
- +2 more
- GM-CSF secreting leukemia vaccine
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 28, 2022
Pancreatic Cancer Trial in Baltimore (PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.)
Recruiting
- Pancreatic Cancer
- PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 3, 2022
Colon Cancer Trial in San Antonio (PalloV-CC)
Recruiting
- Colon Cancer
- PalloV-CC
-
San Antonio, TexasClinical Associates of Research Therapeutics of America
Sep 14, 2022
Pancreatic Cancer Trial in Baltimore (drug, biological, radiation)
Active, not recruiting
- Pancreatic Cancer
- Cyclophosphamide
- +3 more
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 3, 2022
Cytomegalovirus Infection Trial in United States (DBS Self-Collection Kit, Standard Control Strategy)
Recruiting
- Cytomegalovirus Infection
- DBS Self-Collection Kit
- Standard Control Strategy
-
Minneapolis, Minnesota
- +3 more
Aug 18, 2022
Parkinson Disease Trial in Sugar Land (Biological/Vaccine: Allogeneic HB-adMSCs, Placebo)
Recruiting
- Parkinson Disease
- Biological/Vaccine: Allogeneic HB-adMSCs
- Placebo
-
Sugar Land, TexasHope Biosciences Stem Cell Research Foundation
Aug 2, 2021
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +13 more
- CMVpp65-A*0201 peptide vaccine
- +2 more
-
Duarte, California
- +4 more
Jan 4, 2023
Multiple Myeloma Trial in Baltimore (biological, drug, procedure)
Completed
- Multiple Myeloma
- Activated marrow infiltrating lymphocytes
- +6 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 16, 2021